Opioid Peptides Selectively Relax Airway Muscles by Blocking Non-Cholinergic Nerve Signals
Opioid peptides selectively inhibit the non-cholinergic nerve-driven contraction of airway muscle via prejunctional receptors, with dynorphin being the most potent natural peptide.
Quick Facts
What This Study Found
Opioid peptides selectively inhibit non-cholinergic excitatory neurotransmission in airways via prejunctional receptors, with dynorphin being the most potent endogenous peptide.
Key Numbers
How They Did This
Guinea pig bronchial strip chains were electrically stimulated. Responses to opioid peptides and direct muscle stimulants (acetylcholine, substance P) were compared.
Why This Research Matters
Non-cholinergic nerve signaling contributes to airway constriction in asthma. If opioid peptides naturally regulate this pathway, they could be relevant to understanding and treating asthma.
The Bigger Picture
Non-cholinergic nerve signaling contributes to airway constriction in conditions like asthma. The finding that opioid peptides naturally regulate this pathway suggests the endogenous opioid system may help protect against excessive airway narrowing. This could explain why stress and mood affect breathing.
What This Study Doesn't Tell Us
In-vitro study in guinea pig airways. Human airway opioid pharmacology may differ. Only electrical stimulation was used, not natural nerve reflexes.
Questions This Raises
- ?Could opioid-based therapies target airway constriction in asthma?
- ?Is the airway opioid system impaired in severe asthma patients?
Trust & Context
- Key Stat:
- Selective for non-cholinergic contraction Opioid peptides blocked the substance P-driven airway constriction while leaving cholinergic contraction largely intact
- Evidence Grade:
- Preliminary in-vitro study in guinea pig airways. Provides a clear pharmacological profile but direct human airway relevance needs validation.
- Study Age:
- Published in 1990. The role of opioid receptors in airway regulation has been further studied, with clinical relevance to respiratory depression from opioid medications.
- Original Title:
- Morphine and opioid peptides selectively inhibit the non-cholinergically mediated neurogenic contraction of guinea-pig isolated bronchial muscle.
- Published In:
- The Journal of pharmacy and pharmacology, 42(3), 214-6 (1990)
- Authors:
- Kamikawa, Y, Shimo, Y
- Database ID:
- RPEP-00160
Evidence Hierarchy
Frequently Asked Questions
How could opioids help with airway problems?
By blocking the non-cholinergic nerve signals that cause airway constriction, opioid peptides could potentially reduce bronchospasm. However, systemic opioids carry too many risks — a targeted airway approach would be needed.
Why is the selectivity important?
The airways have multiple types of nerve signaling. Opioids specifically target the non-cholinergic pathway (linked to inflammation-driven constriction in asthma) while leaving normal cholinergic airway control mostly intact.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00160APA
Kamikawa, Y; Shimo, Y. (1990). Morphine and opioid peptides selectively inhibit the non-cholinergically mediated neurogenic contraction of guinea-pig isolated bronchial muscle.. The Journal of pharmacy and pharmacology, 42(3), 214-6.
MLA
Kamikawa, Y, et al. "Morphine and opioid peptides selectively inhibit the non-cholinergically mediated neurogenic contraction of guinea-pig isolated bronchial muscle.." The Journal of pharmacy and pharmacology, 1990.
RethinkPeptides
RethinkPeptides Research Database. "Morphine and opioid peptides selectively inhibit the non-cho..." RPEP-00160. Retrieved from https://rethinkpeptides.com/research/kamikawa-1990-morphine-and-opioid-peptides
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.